Your Source for Venture Capital and Private Equity Financings

Venture Capital News: GeneCentric Therapeutics Closes $7.5M Series B1

2021-11-08
DURHAM, NC, GeneCentric Therapeutics, an RNA-based diagnostics startup, raised $7.5 million Series B1 financing.
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced the closing of an oversubscribed Series B1 financing, which raised $7.5 million.

New investors include IAG Capital Partners and Alexandria Venture Investments, along with existing investors Labcorp and Hatteras Venture Partners.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors